Identification of VCAM1 as a Novel Biomarker in the Immune Microenvironment of Gastric Cancer by Comprehensive Bioinformatics Analysis

Xin Jiang,Di Chen,Mengmeng Wang,Yushuang Xu,Mengjun Qiu,Zhifan Xiong

DOI: https://doi.org/10.21203/rs.3.rs-1213974/v1

2022-01-07

Abstract:Abstract Background and Purpose Gastric cancer (GC) is a common malignant tumor of the digestive tract worldwide and has high morbidity and mortality. The tumor immune microenvironment (TIME), especially the immune cell infiltration, plays an important role in the progression and prognosis of GC. In this study, we investigated the TIME-related genes and explored their role in the GC immune microenvironment. Method We used ssGSEA to assess the immune cell infiltration in 375 patients with GC downloaded from TCGA. Then GC samples were divided into high-, medium-, and low-immune cell infiltration groups by hierarchical clustering. Differentially expressed genes analysis were further proceed between groups to determine TIME-related differentially expressed genes (DEGs). By protein interaction network and Cox analysis, the angiogenesis gene was intersected. The results showed that vascular cell adhesion molecular 1 (VCAM1) was the most critical gene. We further analyze the importance of VCAM1 in the progression of GC and its role in the GC microenvironment. Results We identified 463 TIME-associated DEGs and found that VCAM1 was involved in development and prognosis of GC. Further analysis revealed that VCAM1 was involved in the regulation of immune, vascular, and metastasis-related signaling pathways. Immuno-correlation analysis showed that VCAM1 expression was associated with various immune infiltrating cells, including macrophages and T cells. In addition, combined with online database prediction analysis, we speculated that VCAM1 expression in GC could be enhanced by AC104211.1 sponge Has-mir-183-5p. Conclusion VCAM1 may be involved in the regulation of immune state and angiogenesis in the TIME in GC. This protein could be a promising therapeutic target and prognostic biomarker for GC.